Biologics and Nerve Growth Factor (NGF) Inhibitors: Pipeline Targets and Future Growth in the Osteoarthritis Market Trends
The most significant Osteoarthritis Market Trends involve a major strategic shift away from simple symptom relief towards two high-value, novel drug classes: Nerve Growth Factor (NGF) Inhibitors and Disease-Modifying Biologics. Nerve Growth Factor (NGF) Inhibitors: This class, including monoclonal antibodies (mAbs) like those being developed by Eli Lilly and Pfizer, represents a paradigm shift...
0 Reacties 0 aandelen 504 Views 0 voorbeeld